Detection rate of FNA cytology in medullary thyroid carcinoma: A meta-analysis

Clinical Endocrinology

Volumn 82, Issue 2, 2015, Pages 280-285

  Trimboli, Pierpaolo ^a   Treglia, Giorgio ^b   Guidobaldi, Leo ^a   Romanelli, Francesco ^c   Nigri, Giuseppe ^d   Valabrega, Stefano ^d   Sadeghi, Ramin ^e   Crescenzi, Anna ^h   Faquin, William C ^f   Bongiovanni, Massimo ^g   Giovanella, Luca ^b  

^a Ospedale Israelitico di Roma   (Italy)

^b ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ARTICLE; CLINICAL EFFECTIVENESS; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; IMMUNOHISTOCHEMISTRY; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THYROID MEDULLARY CARCINOMA; LABORATORY DIAGNOSIS; PATHOLOGY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

BIOPSY, FINE-NEEDLE; FALSE NEGATIVE REACTIONS; HUMANS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

EID: 84921561695     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12563     Document Type: Article

References (31)

1. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper, D.S., Doherty, G.M., et al,. (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-1214.
2. Kebebew, E., Ituarte, P.H., Siperstein, A.E., et al,. (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer, 88, 1139-1148.
3. Jimènez, C., Hu, M.I., &, Gagel, R.F., (2008) Management of medullary thyroid carcinoma. Endocrinology and Metabolism Clinics of North America, 37, 481-496.
4. Pacini, F., Castagna, M.G., Cipri, C., et al,. (2010) Medullary thyroid carcinoma. Clinical Oncology (Royal College of Radiologists), 22, 475-485.
5. Gharib, H., Papini, E., Paschke, R., et al,. (2010) American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrine Practice, 16, 468-475.
6. Trimboli, P., Giovanella, L., Crescenzi, A., et al,. (2014) Medullary thyroid cancer diagnosis: an appraisal. Head and Neck, 36, 1216-1223.
7. Pusztaszeri, M.P., Bongiovanni, M., &, Faquin, W.C., (2014) Update on the cytologic and molecular features of medullary thyroid carcinoma. Advances in Anatomic Pathology, 21, 26-35.
8. Trimboli, P., Nasrollah, N., Amendola, S., et al,. (2012) Should we use ultrasound features associated with papillary thyroid cancer in diagnosing medullary thyroid cancer? Endocrine Journal, 59, 503-508.
9. Andrioli, M., Trimboli, P., Amendola, S., et al,. (2014) Elastographic presentation of medullary thyroid carcinoma. Endocrine, 45, 153-155.
10. Egger, M., Davey Smith, G., Schneider, M., et al,. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
11. Elisei, R., Bottici, V., Luchetti, F., et al,. (2004) Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. Journal of Clinical Endocrinology and Metabolism, 89, 163-168.
12. Bugalho, M.J., Santos, J.R., &, Sobrinho, L., (2005) Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. Journal of Surgical Oncology, 91, 56-60.
13. Chang, T.C., Wu, S.L., &, Hsiao, Y.L., (2005) Medullary thyroid carcinoma: pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET proto-oncogene mutations. Acta Cytologica, 49, 477-482.
14. Vierhapper, H., Niederle, B., Bieglmayer, C., et al,. (2005) Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid, 15, 1267-1272.
15. Boi, F., Maurelli, I., Pinna, G., et al,. (2007) Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 92, 2115-2118.
16. Kudo, T., Miyauchi, A., Ito, Y., et al,. (2007) Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid, 17, 635-638.
17. Seningen, J.L., Nassar, A., &, Henry, M.R., (2012) Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001-2007: an institutional experience of 1,945 cases. Diagnostic Cytopathology, 40 (Suppl 1), E27-E32.
18. Kaushal, S., Iyer, V.K., Mathur, S.R., et al,. (2011) Fine needle aspiration cytology of medullary carcinoma of the thyroid with a focus on rare variants: a review of 78 cases. Cytopathology, 22, 95-105.
19. Diazzi, C., Madeo, B., Taliani, E., et al,. (2013) The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer. Endocrine Practice, 19, 769-779.
20. Essig, G.F. Jr, Porter, K., Schneider, D., et al,. (2013) Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone. Endocrine Practice, 19, 920-927.
21. Jo, V.Y., Renshaw, A.A., &, Krane, J.F., (2013) Relative sensitivity of thyroid fine-needle aspiration by tumor type and size. Diagnostic Cytopathology, 41, 871-875.
22. Trimboli, P., Cremonini, N., Ceriani, L., et al,. (2014) Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study. Clinical Endocrinology (Oxf), 80, 135-140.
23. Samulski, T.D., Livolsi, V.A., Montone, K., et al,. (2014) The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience. Pathology, Research and Practice, 210, 182-185.
24. Boschin, I.M., Torresan, F., Toniato, A., et al,. (2014) Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications. Endocrine, 45, 448-453.
25. Dustin, S.M., Jo, V.Y., Hanley, K.Z., et al,. (2012) High sensitivity and positive predictive value of fine-needle aspiration for uncommon thyroid malignancies. Diagnostic Cytopathology, 40, 416-421.
26. Trimboli, P., Nigri, G., Romanelli, F., et al,. (2012) Medullary thyroid nodules by measurement of calcitonin (Ct) in aspiration needle washout in patients with multinodular goiter and moderately elevated serum Ct. Experimental and Clinical Endocrinology & Diabetes, 120, 234-237.
27. Trimboli, P., Rossi, F., Baldelli, R., et al,. (2012) Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer. Diagnostic Cytopathology, 40, 394-398.
28. Colombo, C., Verga, U., Mian, C., et al,. (2012) Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 97, 905-913.
29. Papaparaskeva, K., Nagel, H., &, Droese, M., (2000) Cytologic diagnosis of medullary carcinoma of the thyroid gland. Diagnostic Cytopathology, 22, 351-358.
30. Forrest, C.H., Frost, F.A., de Boer, W.B., et al,. (1998) Medullary carcinoma of the thyroid: accuracy of diagnosis of fine-needle aspiration cytology. Cancer, 84, 295-302.
31. Trimboli, P., Guidobaldi, L., Crescenzi, A., et al,. (2014) The essential use of FNA-calcitonin for detecting medullary thyroid cancer. Endocrine. doi: 10.1007/s12020-014-0226-x.